Sclerostin ELISA

$693.00
Catalog
04-BI-20492

The Sclerostin ELISA is intended for the quantitative determination of sclerostin in Human serum, EDTA plasma or heparin plasma.

  • Includes controls and standards
  • Small sample volume requirement: 20 µL
  • Colorimetric Detection
  • Excellent precision and reproducibility
  • Intra-assay CV 7%
  • Inter-assay CV 10%

For Research Use Only. Not for Use in Diagnostic Procedures.

Species
Human
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
Product Distribution
Available in North America Only
Range
15-240 pM
Sensitivity
2.6 pM
Sizes
96 Wells
Sample Types
EDTA Plasma, Heparin Plasma, Serum
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
20
Detection
Colorimetric

Sclerostin (SOST) is a 22.5 kD secreted glycoprotein produced in osteocytes and is considered a highly specific biomarker for bone. SOST inhibits osteoblast activity via antagonism of the Wnt Signaling pathway and plays a key role in the regulation of bone formation.

SOST levels are of interest in many research fields including bone metabolic diseases, multiple myeloma, chronic kidney disease, type 2 diabetes, and chronic inflammation.

Sclerostin ELISA

04-BI-20492

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

GLP-1 Amide Elisa
Product Data: Active GLP-1 (7-36) amide Chemiluminescence ELISA
ALPCO’s Active GLP-1 (7-36) amide Chemiluminescence ELISA accurately measures the major biologically active circulating form of GLP-1.1,2 This well-characterized assay provides high analytical sensitivity, a short incubation time, and measures active GLP-1 (7-36) amide in fasted and fed samples.
View Now
 Total Proinsulin Chemiluminescence ELISA
Product Data: Total Proinsulin Chemiluminescence ELISA
ALPCO’s Total Proinsulin Chemiluminescence ELISA offers excellent sensitivity and the greatest dynamic range on the market. 
View Now
Rodent Insulin Chemiluminescence ELISA
Product Data: Rodent Insulin Chemiluminescence ELISA
The STELLUX® Rodent Insulin ELISA provides the flexibility to run both mouse and rat samples on the same plate with minimal to no dilution and a short two hour incubation.
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.